Scott & Selber Inc’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-15,214
Closed -$1.75M 87
2019
Q3
$1.75M Buy
15,214
+18
+0.1% +$2.73K 0.89% 56
2019
Q2
$2.62M Buy
15,196
+1,163
+8% +$201K 1.32% 30
2019
Q1
$2.37M Sell
14,033
-44
-0.3% -$6.55K 1.24% 36
2018
Q4
$1.37M Sell
14,077
-1,816
-11% -$238K 0.84% 55
2018
Q3
$2.75M Buy
+15,893
New +$2.29M 1.35% 33

Other funds holding GWPH

Scott & Selber Inc's GWPH Position: Q4 2019 in Review

Scott & Selber Inc sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2019, closing a stake of 15,214 shares — an estimated $1.75M sold.

Scott & Selber Inc first reported a position in GWPH in Q3 2018 and held it in 5 quarters. The position peaked at $2.75M in Q3 2018. 318 funds tracked by Wall St. Rank hold GWPH as of Q4 2019.

  • Scott & Selber Inc reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
  • Scott & Selber Inc sold 15,214 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2019, an estimated $1.75M.
  • Scott & Selber Inc first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 5 quarters.
  • Scott & Selber Inc's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.75M in Q3 2018.
  • 318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2019.

Based on Scott & Selber Inc's 13F filing for Q4 2019, filed 7 Feb 2020.